Focused on environmental pollution from raw materials used to make antibiotics at the very beginning of the supply chain, the campaign’s objective is to expose the links between polluting factories in China and India and some of the biggest global pharmaceutical companies.
Advocacy work based on on-the-ground investigations in India and China and desk research, involving numerous stakeholders.
- Hyderabad’s pharmaceutical pollution crisis: heavy metal and solvent contamination at factories in a major Indian drug manufacturing hub
- Superbugs in the supply chain: how pollution from antibiotics factories in India and China is fuelling the global rise of drug-resistant infections
- Drug resistance through the back door: how the pharmaceutical industry is fuelling the rise of superbugs through pollution in its supply chains
- Impacts of pharmaceutical pollution on communities and environment in India
- Bad Medicine – How the pharmaceutical industry is contributing to the global rise of antibiotic-resistant superbugs
HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.
